2024
The economics of heart failure care. Progress in cardiovascular diseasesWei, C., Heidenreich, P. A., Sandhu, A. T.
Assessment of Price Variation in Coronary Artery Bypass Surgery at US Hospitals. Journal of the American Heart AssociationWei, C., Paranjpe, I., Sharma, P., Milligan, M., Lam, M., Heidenreich, P. A., Kalwani, N., Schulman, K., Sandhu, A.2024: e031982
Healthcare utilization and left ventricular ejection fraction distribution in methamphetamine use associated heart failure hospitalizations. American heart journalManja, V., Sandhu, A. T., Asch, S., Frayne, S., McGovern, M., Chen, C., Heidenreich, P.
2023
Sandhu AT, Heidenreich PA, Borden W, Farmer SA, Ho PM, Hammond G, Johnson JC, Wadhera RK, Wasfy JH, Biga C, Takahashi E, Misra KD, Joynt Maddox KE; American Heart Association Advocacy Coordinating Committee. Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. 2023 Jul 10.
Wei C, Milligan M, Lam M, Heidenreich PA, Sandhu A. Variation in Cost of Echocardiography Within and Across US Hospitals. J Am Soc Echocardiogr. 2023 Jan 10:S0894-7317(23)00006-8.
2022
Tisdale RL, Ferguson J, Van Campen J, Greene L, Sandhu AT, Heidenreich PA, Zulman DM. Disparities in virtual cardiology visits among Veterans Health Administration patients during the COVID-19 pandemic. JAMIA Open. 2022 Dec 15;5(4):ooac103.
Zheng J, Parizo JT, Spertus JA, Heidenreich PA, Sandhu AT. Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Intern Med. 2022 Dec 1;182(12):1278-1288. doi: 10.1001/jamainternmed.2022.5010.
Koos H, Parameswaran V, Claire S, Chen C, Kalwani N, Osmanlliu E, Qureshi L, Dash R, Scheinker D, Rodriguez F. Drivers of variation in telemedicine use during the COVID-19 pandemic: The experience of a large academic cardiovascular practice. J Telemed Telecare. 2022 Oct 9:1357633X221130288.
Tisdale RL, Cusick MM, Aluri KZ, Handley TJ, Joyner AKC, Salomon JA, Chertow GM, Goldhaber-Fiebert JD, Owens DK. Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease. J Gen Intern Med. 2022 Oct;37(13):3380-3387.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032.
Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ; HFSA Scientific Statement Committee Members Chair. Economic Issues in Heart Failure in the United States. J Card Fail. 2022 Mar;28(3):453-466.
Kalwani NM, Osmanlliu E, Parameswaran V, Qureshi L, Dash R, Heidenreich PA, Scheinker D, Rodriguez F. Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemic. J Telemed Telecare. 2022 Feb 2:1357633X211073428.
Sandhu AT, Heidenreich PA, Lin J, Parizo J, Bhattacharya J, Goldhaber-Fiebert JD. Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan. Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e007993.
2021
Vasti EC, Ouyang D, Ngo S, Sarraju A, Harrington RA, Rodriguez F. Gender Disparities in Cardiology-Related COVID-19 Publications. Cardiol Ther. 2021 Dec;10(2):593-598.
Ma I, Tisdale RL, Vail D, Heidenreich PA, Sandhu AT. Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program. Circ Cardiovasc Qual Outcomes. 2021 Dec;14(12):e007559.
Kalwani NM, Wang KM, Johnson AN, Deb JD, Gold T, Maddukuri AK, Savage EG, Parameswaran V, Dash R, Scheinker D, Rodriguez F. Application of the Quadruple Aim to evaluate the operational impact of a telemedicine program. Healthc (Amst). 2021 Dec;9(4):100593.
Kalwani NM, Johnson AN, Parameswaran V, Dash R, Rodriguez F. Initial Outcomes of CardioClick, a Telehealth Program for Preventive Cardiac Care: Observational Study. JMIR Cardio. 2021 Sep 9;5(2):e28246.
Parizo JT, Goldhaber-Fiebert JD, Salomon JA, Khush KK, Spertus JA, Heidenreich PA, Sandhu AT. Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. 2021 Aug 1;6(8):926-935.
Tisdale RL, Ma I, Vail D, Bhattacharya J, Goldhaber-Fiebert JD, Heidenreich PA, Sandhu AT. Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures. JAMA Netw Open. 2021 Jun 1;4(6):e2113969.
Duseja R, Andress J, Sandhu AT, Bhattacharya J, Lam J, Nagavarapu S, Nilasena D, Choradia N, Do R, Feinberg L, Bounds S, Leoung J, Luo B, Swygard A, Uwilingiyimana AS, MaCurdy T. Development of Episode-Based Cost Measures for the US Medicare Merit-based Incentive Payment System. JAMA Health Forum. 2021 May 6;2(5):e210451.
Sandhu AT, Do R, Lam J, Blankenship J, Van Decker W, Rich J, Gonzalez O, Wu X, Pershing S, Lin E, MaCurdy TE, Bhattacharya J, Nagavarapu S; Elective Outpatient PCI Cost Measure Writing Group. Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure. Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e006461.
Heidenreich PA, Estes NAM 3rd, Fonarow GC, Jurgens CY, Kittleson MM, Marine JE, McManus DD, McNamara RL. 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2021 Jan 26;77(3):326-341.
Heidenreich PA, Estes NAM 3rd, Fonarow GC, Jurgens CY, Kittleson MM, Marine JE, McManus DD, McNamara RL. 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e000100.
Parizo JT, Desai M, Rodriguez F, Sandhu AT, Khush KK. Evaluation of variation in insurance payor mix among heart transplant centers. J Heart Lung Transplant. 2021 Jan;40(1):65-68.
2020
Heidenreich PA, Fonarow GC, Breathett K, Jurgens CY, Pisani BA, Pozehl BJ, Spertus JA, Taylor KG, Thibodeau JT, Yancy CW, Ziaeian B. 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2020 Nov 24;76(21):2527-2564.
Yong CM, Ang L, Welt FGP, Gummidipundi S, Henry TD, Pinto DS, Cox D, Wang P, Asch S, Mahmud E, Fearon WF; Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) Interventional Council. Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. Catheter Cardiovasc Interv. 2020 Nov;96(5):1080-1086.
Sandhu AT, Bhattacharya J, Lam J, Bounds S, Luo B, Moran D, Uwilingiyimana AS, Fenson D, Choradia N, Do R, Feinberg L, MaCurdy T, Nagavarapu S. Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost Measures. Health Aff (Millwood). 2020 Sep;39(9):1495-1503.
Sandhu AT, Tisdale R, Joynt Maddox KE, Heidenreich PA. Association Between Neighborhood Social Risk and Hospital Readmission Reduction Penalties Under the New Stratified Approach: Is Dual Eligibility Adjustment Enough? Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006353.
Yong CM, Tremmel JA, Lansberg MG, Fan J, Askari M, Turakhia MP. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation. J Am Heart Assoc. 2020 May 18;9(10):e015689.
Manjunath L, Chung S, Li J, Shah H, Palaniappan L, Yong CM. Heterogeneity of Treatment and Outcomes Among Asians With Coronary Artery Disease in the United States. J Am Heart Assoc. 2020 May 18;9(10):e014362.
2019
Sandhu AT, Kohsaka S, Bhattacharya J, Fearon WF, Harrington RA, Heidenreich PA. Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates. JAMA Cardiol. 2019 Nov 1;4(11):1077-1083.
Sandhu AT, Heidenreich PA. Comparison of the change in heart failure readmission and mortality rates between hospitals subject to hospital readmission reduction program penalties and critical access hospitals. Am Heart J. 2019 Mar;209:63-67.
2018
Perino AC, Fan J, Schmitt SK, Kaiser DW, Heidenreich PA, Narayan SM, Wang PJ, Chang AY, Turakhia MP. Patient and facility variation in costs of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018 Aug;29(8):1081-1088.
2017
Heidenreich PA, Zapata A, Shieh L, Oliva N, Sahay A. Patient ratings of Veterans Affairs and affiliated hospitals. Am J Manag Care. 2017 Jun;23(6):382-384.
Sandhu AT, Ollendorf DA, Chapman RH, Pearson SD, Heidenreich PA. Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction. Ann Intern Med. 2017 Apr 18;166(8):607-608.